Education Hub

Law & Ethics

Legal considerations, ethical frameworks, and responsible approaches to education and community.

16 articles available

Related Journal Articles

Psychedelic Alpha
Law & Ethics
Mental Health

Field Notes #6: Dispatches from D.C. as Three Psychedelics Land at FDA

Field Notes are timely, candid voice notes from our Founder and Editor, Josh Hardman, that give our Pα+ readers a pulse on recent developments in psychedelic drug development, policy, and access.

EvanderNov 13, 20261 min
Psychedelics Today
Law & Ethics
Research & History

Robert Rush: Emergency Scheduling, 7-OH, and the War on Research

Attorney Robert Rush joins Joe in Breckenridge to talk about challenging DEA scheduling decisions, from the 2024 DOI and DOC hearing to the emergency scheduling of 7-OH compounds and SR-17018.

Psychedelics TodayNov 5, 20261 min
Psychedelics Today
Research & History

The Problems We Will Be Lucky to Have

In November 2020, Oregon voters passed the first ballot measure in the country to create a legal, supervised psilocybin program, Measure 109.

Psychedelics TodayNov 4, 20269 min
Psychedelic Alpha
Law & Ethics
Mental Health

Usona Files Psilocybin for Depression NDA as Race With Compass Tightens

Nonprofit psychedelic research organisation Usona Institute has completed its submission of a new drug application (NDA) to the U.S.

EvanderNov 2, 20261 min
Psychedelic Alpha
Law & Ethics

FDA Approves NRx’s Preservative-Free Generic Ketamine, but Its Bid to Ban Rivals’ Products Remains Pending

This morning, NRx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Abbreviated New Drug Application (ANDA) for its preservative-free ketamine produ...

EvanderOct 30, 20261 min
Lucid News
Law & Ethics
Research & History

Oregon U-turns on Doubling Psilocybin License Fees

Oregon’s health regulators shelved a proposal that would have doubled what psilocybin businesses and facilitators pay for their state licenses.

Joseph GallivanOct 22, 20265 min
Psychedelics Today
Law & Ethics
Harm Reduction

From Ecstasy Rising to Peaking: Jordan Kronick on 20 Years Covering Psychedelics

Documentary filmmaker Jordan Kronick joins Joe to discuss Peaking: Psychedelics and the Pursuit of Happiness, a new psychedelic documentary that takes cameras into the dosing room across six psychedel...

Psychedelics TodayOct 21, 20261 min
Psychedelics Today
Research & History
Law & Ethics

Weekly Psychedelic Policy Briefing: October 12, 2026

FDA laid out how the first federally funded ibogaine trials could be run, with inpatient cardiac monitoring and a 10 mg/kg starting dose ceiling.

Psychedelics TodayOct 12, 20261 min
Psychedelics Today
Law & Ethics
Harm Reduction

Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health

Kenneth Tupper joins Joe Moore for a wide-ranging conversation on harm reduction, drug education, British Columbia’s toxic drug crisis, ayahuasca policy, entheogenic education, and what psychedelic pu...

Psychedelics TodayOct 7, 20261 min
MAPS
Law & Ethics
Harm Reduction

2026 Third Quarter — Legislative Wrap Up

Since the beginning of 2026, at least 23 states have introduced psychedelic legislation, signaling continued momentum and openness in how local and federal leaders address mental health, substance use...

Kevin CranfordOct 6, 20267 min
MAPS
Law & Ethics
Mental Health

MAPS and International Alliance of Psychedelic Therapy Practitioners Announce Partnership to Advance Training for Psychedelic-Assisted Therapy

Collaboration will increase access to practitioner education in the United States and internationally.

Kevin CranfordOct 5, 20266 min
Psychedelic Alpha
Law & Ethics

Quarterly Psychedelics Briefing: Q3 2026

Welcome to our Q3 2026 Quarterly Briefing. Every three months, our Founder & Editor Josh Hardman walks you through major developments from the prior quarter across drug development, policy and reg...

EvanderOct 2, 20261 min
MAPS
Law & Ethics
Research & History

Statement on DEA attempt to reschedule five tryptamines

Last week, the DEA moved to place five little-known psychedelic compounds — 4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET, and DiPT — into Schedule I of the Controlled Substances Act.

Kevin CranfordSep 29, 20262 min

By continuing to use this site, you agree to our Terms and Privacy Policy.

Common questions

What does Law & Ethics cover?
This section covers legal context, ethical frameworks, and responsible approaches to education and community.
Does the section provide transaction or legal instructions?
No. It provides neutral education and does not offer transaction guidance or advice for a specific legal situation.